Metabolite identification (METID) of NCGC00686670 in plateable hepatocytes of mouse, RAT, DOG, monkey and human - covid-19

Ended Purchase Order Awarded Last action

Contract number
75N95021P00012
Awardee
Awarding agency
Obligated
$18,500

Award facts

Opportunity
  • 75N95021Q00007 Solicitation number
Contract value 100% obligated
$18,500.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Exton, PA 19341, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$4,000
Original award $22,500

About this award

The National Institute on Drug Abuse awarded a purchase order to Frontage Laboratories Inc. for $18,500.00 on November 11, 2020, for metabolite identification of compound NCGC00686670 in plateable hepatocytes of mouse, rat, dog, monkey, and human species, with COVID-19 context. The awardee is a minority-owned, Asian-Pacific American owned business. Work is performed at Frontage Laboratories' facility in Exton, Pennsylvania. The order carries a firm fixed price and is scheduled for completion by December 23, 2020.

Quick answers

Who was awarded contract 75N95021P00012?

75N95021P00012 was awarded to Frontage Laboratories Inc. by National Institute on Drug Abuse (National Institutes of Health) on November 11, 2020.

How much is contract 75N95021P00012 worth?

The government has obligated $18,500 on 75N95021P00012.

Was contract 75N95021P00012 competed?

The extent of competition for 75N95021P00012 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award